{"id":"https://openalex.org/W2117347703","doi":"https://doi.org/10.3109/08977199109000295","title":"Expression of Recombinant TGF-\u03b22(442) Precursor and Detection in BSC-40 Cells","display_name":"Expression of Recombinant TGF-\u03b22(442) Precursor and Detection in BSC-40 Cells","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W2117347703","doi":"https://doi.org/10.3109/08977199109000295","mag":"2117347703","pmid":"https://pubmed.ncbi.nlm.nih.gov/1777240"},"language":"en","primary_location":{"id":"doi:10.3109/08977199109000295","doi":"https://doi.org/10.3109/08977199109000295","is_oa":false,"landing_page_url":"https://doi.org/10.3109/08977199109000295","pdf_url":null,"source":{"id":"https://openalex.org/S152803389","display_name":"Growth Factors","issn_l":"0897-7194","issn":["0897-7194","1026-7964","1029-2292"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Growth Factors","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086083160","display_name":"Linda Madisen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Madisen","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059191263","display_name":"Mario N. Lioubin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario N. Lioubin","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082515242","display_name":"P.J. Finerty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J. Finerty","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110313894","display_name":"Karl Sutter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl Sutter","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072794613","display_name":"James Blake","orcid":"https://orcid.org/0000-0001-9769-8529","observed_orcids":["https://orcid.org/0000-0001-9769-8529"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Blake","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002620743","display_name":"Judith Frederick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith Frederick","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087920067","display_name":"A F Purchio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. F. Purchio","raw_affiliation_strings":["Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Pharmaceutical Research Institute 3005 First Avenue, Seattle, WA, 98121, USA","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":0.1113,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.36306004,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"4","first_page":"317","last_page":"325"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tgf-beta2","display_name":"TGF-beta2","score":0.8759999871253967},{"id":"https://openalex.org/keywords/alternative-mrna-splicing","display_name":"alternative mRNA splicing","score":0.8309999704360962},{"id":"https://openalex.org/keywords/propeptide","display_name":"propeptide","score":0.6899999976158142},{"id":"https://openalex.org/keywords/latent-tgf-beta","display_name":"latent TGF-beta","score":0.6549999713897705},{"id":"https://openalex.org/keywords/recombinant-protein-expression","display_name":"recombinant protein expression","score":0.7049999833106995},{"id":"https://openalex.org/keywords/anti-peptide-antibodies","display_name":"anti-peptide antibodies","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cho-cells","display_name":"CHO cells","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.7722144722938538},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.7068163156509399},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.6753281354904175},{"id":"https://openalex.org/C187882448","wikidata":"https://www.wikidata.org/wiki/Q283478","display_name":"Complementary DNA","level":3,"score":0.649793267250061},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5852539539337158},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5783334970474243},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.5768681168556213},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5423181653022766},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.45744723081588745},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.44542235136032104},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.4315093159675598},{"id":"https://openalex.org/C91523082","wikidata":"https://www.wikidata.org/wiki/Q420496","display_name":"Antiserum","level":3,"score":0.4292992353439331},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.42908263206481934},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.42653852701187134},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38604485988616943},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3234489858150482},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19319897890090942},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07734781503677368}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010957","descriptor_name":"Plasmids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/08977199109000295","doi":"https://doi.org/10.3109/08977199109000295","is_oa":false,"landing_page_url":"https://doi.org/10.3109/08977199109000295","pdf_url":null,"source":{"id":"https://openalex.org/S152803389","display_name":"Growth Factors","issn_l":"0897-7194","issn":["0897-7194","1026-7964","1029-2292"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Growth Factors","raw_type":"journal-article"},{"id":"pmid:1777240","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1777240","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Growth factors (Chur, Switzerland)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W143417350","https://openalex.org/W210896705","https://openalex.org/W1495519011","https://openalex.org/W1524114372","https://openalex.org/W1561326647","https://openalex.org/W1561938123","https://openalex.org/W1595226323","https://openalex.org/W1600868878","https://openalex.org/W1605241473","https://openalex.org/W1608791497","https://openalex.org/W1660743658","https://openalex.org/W1676134956","https://openalex.org/W1787673447","https://openalex.org/W1884021146","https://openalex.org/W1894312995","https://openalex.org/W1963932192","https://openalex.org/W1966507279","https://openalex.org/W1972456273","https://openalex.org/W1973644988","https://openalex.org/W1979877257","https://openalex.org/W1984172347","https://openalex.org/W1987408592","https://openalex.org/W1996623331","https://openalex.org/W2002491528","https://openalex.org/W2002946136","https://openalex.org/W2003075395","https://openalex.org/W2020568173","https://openalex.org/W2027726633","https://openalex.org/W2039299132","https://openalex.org/W2044946668","https://openalex.org/W2047038838","https://openalex.org/W2050687675","https://openalex.org/W2052589062","https://openalex.org/W2057848088","https://openalex.org/W2058892394","https://openalex.org/W2075018426","https://openalex.org/W2078772718","https://openalex.org/W2084099638","https://openalex.org/W2084740281","https://openalex.org/W2086833378","https://openalex.org/W2092671785","https://openalex.org/W2096525503","https://openalex.org/W2100837269","https://openalex.org/W2101281838","https://openalex.org/W2101916574","https://openalex.org/W2108229785","https://openalex.org/W2111817213","https://openalex.org/W2115598567","https://openalex.org/W2136819827","https://openalex.org/W2139839934","https://openalex.org/W2141750508","https://openalex.org/W2146146808","https://openalex.org/W2150472477","https://openalex.org/W2152310987","https://openalex.org/W2155383324","https://openalex.org/W2159579113","https://openalex.org/W2161454032","https://openalex.org/W2164279207","https://openalex.org/W2336518283","https://openalex.org/W2609166480"],"related_works":["https://openalex.org/W2003075395","https://openalex.org/W2146146808","https://openalex.org/W1985912159","https://openalex.org/W1996623331","https://openalex.org/W1884021146","https://openalex.org/W2152310987","https://openalex.org/W2336518283","https://openalex.org/W2075018426","https://openalex.org/W1608791497","https://openalex.org/W2096525503"],"abstract_inverted_index":{"Analysis":[0],"of":[1,48,75,181,193,230],"cDNA":[2,64,154],"clones":[3,97],"encoding":[4,155],"transforming":[5],"growth":[6,77],"factor":[7],"(TGF)-beta":[8],"2":[9,103],"predicts":[10],"two":[11,36,165],"different":[12],"precursor":[13,24,32,207],"proteins":[14,37,58,130,143],"derived":[15],"by":[16,39,60,105,136,149,200,212],"alternative":[17],"mRNA":[18],"splicing;":[19],"a":[20,28,40,213,223],"414":[21],"amino":[22,30,42,177],"acid":[23,31,43,178],"[TGF-beta":[25,33],"2(414)]":[26],"and":[27,65,210],"442":[29],"2(442)].":[34],"The":[35,101],"differ":[38],"28":[41,176],"insertion":[44],"within":[45],"the":[46,55,61,73,164,175,191,204,228],"pro-region":[47,128],"TGF-beta":[49,56,62,99,102,123,156,182,194,205,231],"2(442).":[50,100,183],"In":[51,119],"order":[52],"to":[53,114,121,189],"characterize":[54],"2-related":[57],"encoded":[59],"2(442)":[63,195,206],"determine":[66],"whether":[67],"it":[68,220],"could,":[69],"in":[70,84,172,196,226],"fact,":[71],"direct":[72],"synthesis":[74],"active":[76],"factor,":[78],"we":[79],"have":[80],"expressed":[81],"this":[82,217],"gene":[83],"Chinese":[85],"hamster":[86],"ovary":[87],"(CHO)":[88],"cells":[89,107,151],"and,":[90],"after":[91],"amplification":[92],"with":[93,153],"methotrexate,":[94],"obtained":[95],"stable":[96],"secreting":[98],"secreted":[104,133,148,211],"these":[106],"was":[108,112,170,186],"latent":[109],"as":[110,134],"acidification":[111],"necessary":[113],"detect":[115,190],"optimal":[116],"biological":[117],"activity.":[118],"addition":[120],"mature":[122],"2,":[124],"high":[125],"molecular":[126],"weight":[127],"containing":[129],"were":[131],"also":[132],"analyzed":[135],"immunoblotting":[137],"using":[138],"site-specific":[139],"anti-peptide":[140,168],"antibodies.":[141],"These":[142],"migrated":[144],"differently":[145],"than":[146],"those":[147],"CHO":[150],"transfected":[152],"2(414),":[157],"indicating":[158],"that":[159,219],"structural":[160],"differences":[161],"exist":[162],"between":[163],"complexes.":[166],"An":[167],"antiserum":[169],"produced":[171,209],"rabbits":[173],"against":[174],"insert":[179],"region":[180],"This":[184],"sera":[185],"then":[187],"used":[188],"presence":[192],"serum-free":[197],"media":[198],"conditioned":[199],"BSC-40":[201],"cells.":[202],"Since":[203],"is":[208],"non-recombinant":[214],"cell":[215],"line,":[216],"suggests":[218],"may":[221],"play":[222],"physiological":[224],"role":[225],"regulating":[227],"activity":[229],"2.":[232]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}